Pharmaceutical Technology
MAY 9, 2024
Clinical trials are growing across Africa as the immense potential of the continent starts to be realised. Sponsors and CROs are tapping into the unsaturated patient pools, more diverse populations, and competitive operations costs.
Bio Pharma Dive
MAY 9, 2024
The company is discontinuing an array of early drug programs, including several in oncology, as it prioritizes investment in six late-stage assets.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
MAY 9, 2024
Anixa Biosciences has expanded its partnership with Cleveland Clinic to develop additional vaccines for cancers.
AuroBlog - Aurous Healthcare Clinical Trials blog
MAY 9, 2024
Virus containing droplets were suspended in the CELEBS experimental device for different durations before infectivity was tested. (Allen Haddrell/University of Bristol) Keeping CO2 levels low reduces infectious airborne viral loads, new research suggests.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Bio Pharma Dive
MAY 9, 2024
The deal with Metaphore Biotechnologies is the third to emerge from a Flagship alliance that’s meant to boost the Danish drugmaker’s pipeline of weight loss medicines.
AuroBlog - Aurous Healthcare Clinical Trials blog
MAY 9, 2024
India’s export of Ayush and herbal products has reported a growth of 3.6 per cent during the fiscal year 2023-24, at $651.17 million as compared to the same period of previous year, registering a below-five per cent growth for the second consecutive year. The country reported exports of 10.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Pharmaceutical Technology
MAY 9, 2024
Workforce optimisation, R&D prioritisation and technology investments are on Takeda’s agenda.
Pharma Times
MAY 9, 2024
Anticancer drugs will be responsible for 90% of nearly 612,000 predicted US cancer deaths in 2024
Pharmaceutical Technology
MAY 9, 2024
Rakovina has expanded research collaborations with Pharma Inventor and the University of British Columbia to identify novel drug candidates.
Fierce Pharma
MAY 9, 2024
Five months out from their twin FDA approvals in sickle cell disease (SCD), who’s winning the race to treat patients with their respective gene therapies—bluebird bio or partners Vertex Pharmaceuti | Five months out from their twin FDA approvals in sickle cell disease (SCD), who’s winning the race to treat patients with their respective gene therapies—bluebird bio or partners Vertex Pharmaceuticals and CRISPR Therapeutics?
Pharmaceutical Technology
MAY 9, 2024
Acumen Pharmaceuticals has dosed the first patient in the ALTITUDE-AD Phase II trial for its lead drug sabirnetug (ACU193).
Pharma Times
MAY 9, 2024
The subtype accounts for 20% of all T-cell leukaemias, a rare form of blood cancer which produces too many abnormal T-cells
Pharmaceutical Technology
MAY 9, 2024
The Danish biotech, Commit Biologics, will focus on developing antibody therapies to treat cancer and autoimmune diseases.
pharmaphorum
MAY 9, 2024
Jennifer Goldsack of DiME talks in this podcast about the ROI for digital endpoints for pharma. Data shows digital endpoints drives meaningful engagement with healthcare providers.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Pharmaceutical Technology
MAY 9, 2024
Marinus expects to share data from the Phase III RAISE trial of IV ganaxolone for the treatment of status epilepticus later in the summer.
Fierce Pharma
MAY 9, 2024
After telegraphing more than a hundred potential layoffs in March in connection with plans to stop construction of a massive Seagen facility, Pfizer is plowing ahead with efforts to streamline its | Pfizer has proposed another round of staff reductions and role changes at legacy Seagen, this time hitting Seagen’s European headquarters in Switzerland, where 74 positions could be up for the chop.
Pharmaceutical Technology
MAY 9, 2024
A research project between DMU and the University of Surrey received a grant to help reduce costs for companies in developing medicines.
Fierce Pharma
MAY 9, 2024
While Merck & Co.’s Keytruda already boasts a pair of approvals to treat certain forms of endometrial cancer, a recent effort to prove the PD-1 inhibitor’s worth as a post-surgery add-on therap | While Merck & Co.’s Keytruda already boasts a pair of approvals to treat certain forms of endometrial cancer, a recent effort to prove the PD-1 inhibitor’s worth as a post-surgery add-on therapy in newly diagnosed patients has fallen short.
Pharmaceutical Technology
MAY 9, 2024
The GHIT Fund announced an investment of Y1.64bn ($10.8m) in four new projects aimed at developing drugs to treat malaria and NTDs.
pharmaphorum
MAY 9, 2024
A UK report has said that inflation and geopolitical instability have led to a “dramatic drop” in investment in smaller companies developing new medicines, with a knock-on effect on the entire life sciences industry.
Pharmaceutical Technology
MAY 9, 2024
Sobi gains approval for an indication extension from the European Commission for Aspaveli for adults with PNH who have haemolytic anaemia.
pharmaphorum
MAY 9, 2024
12 Questions with Pilar de la Rocha Mur Mike.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Fierce Pharma
MAY 9, 2024
As argenx continues to scoop up biologics market share with its antibody fragment Vyvgart in generalized myasthenia gravis (gMG), the Dutch immunology outfit is confident that it’s “just at the beg | As argenx continues to scoop up biologics market share with its antibody fragment Vyvgart in generalized myasthenia gravis, the Dutch immunology outfit is confident that it’s “just at the beginning of the growth curve” in its inaugural indication.
pharmaphorum
MAY 9, 2024
Google DeepMind and Isomorphic Labs' newly launched AlphaFold 3 extends the power of the AI model to 'all life’s molecules'
Pharmaceutical Commerce
MAY 9, 2024
In an interview with Pharma Commerce Editor Nicholas Saraceno, Cathy O'Brien, VP of Sales, UPS Healthcare discusses her masterclass on delivering agility in supply chains by building a multimodal cold chain network while also reducing risks at LogiPharma Europe 2024.
pharmaphorum
MAY 9, 2024
How have drug container closure testing methods changed over time? This post explores the history and development of techniques to evaluate container integrity.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Pharmaceutical Commerce
MAY 9, 2024
The latest news for pharma industry insiders.
pharmaphorum
MAY 9, 2024
A new metric developed by Phesi can predict the burden that clinical trials will impose on patients, allowing amendments that can improve the design, efficiency and cost
XTalks
MAY 9, 2024
This episode of the Xtalks Food Podcast features an interview with Cally Edgren, a PFAS expert and the Senior Director of Sustainability at Assent, a leader in supply chain sustainability management solutions. Cally starts off by explaining what PFAS chemicals are and why they are so prevalent in the food industry. She delves into the details of a federal PFAS ban that was proposed in April and how it would impact businesses if passed.
Fierce Pharma
MAY 9, 2024
US gene therapy approvals create a big problem for Brazil.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Expert insights. Personalized for you.
130 
Let's personalize your content